Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.
Craif has raised $2.1M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2025.
Craif's investors include ANRI, Global Brain Corporation, Aozora Corporate Investment, Daiwa Corporate Investment, NEDO.
Craif is headquartered in Tokyo, Japan.
Craif is a biotechnology company that develops a cancer diagnosis algorithm using microRNA database and machine learning technology.
Craif is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Craif — Funding & Investors." VCBacked, April 28, 2025, https://www.vcbacked.co/company/craif. Accessed November 12, 2026.
VCBacked. (2025). Craif — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/craif
{{cite web |title=Craif — Funding & Investors |url=https://www.vcbacked.co/company/craif |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Craif? Request a listing update